J. Shupack

发表

Three-dimensional imaging for diagnostic ultrasound in dermatology.

J Driller, F L Lizzi, F. Lizzi, 1993, Journal of the American Academy of Dermatology.

Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.

P. Pochi, R. Dobson, W. Jordan, 1981, Archives of dermatology.

The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.

R. Auerbach, H. Feiner, J. Shupack, 1989, Archives of dermatology.

DIAGNOSTIC HIGH‐RESOLUTION ULTRASOUND IN DERMATOLOGY

F. Lizzi, M. Rorke, J. Driller, 1993, International journal of dermatology.

Diagnostic ultrasound in dermatology: current uses and future potential.

F. Lizzi, M. Rorke, J. Driller, 1994, Cutis.

Alefacept in the treatment of psoriatic nail disease: a small case series.

B. Strober, J. Shupack, A. Alexis, 2005, Journal of American Academy of Dermatology.

Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient.

M. Stiller, J. Shupack, L. Teperman, 1994, Journal of the American Academy of Dermatology.

A portable pulsed electromagnetic field (PEMF) device to enhance healing of recalcitrant venous ulcers: a double‐blind, placebo‐controlled clinical trial

M. Stiller, J. Shupack, C. Kenny, 1992, The British journal of dermatology.

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.

J. Shupack, K. Washenik, G. Pak, 1996, Journal of the American Academy of Dermatology.

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.

C. Elmets, T. Kuzel, E. Olsen, 2001, Journal of the American Academy of Dermatology.

The glucagonoma syndrome.

D. M. Stevens, J. Shupack, P. Berczeller, 1978, The Journal of dermatologic surgery and oncology.

Enhanced antibody titers to an oxidized DNA base in inflammatory and neoplastic diseases

M. Stiller, J. Shupack, K. Frenkel, 1992, Experimental dermatology.

Cyclosporine as maintenance therapy in patients with severe psoriasis.

D. Margolis, R. Freinkel, E. Bauer, 1997, Journal of the American Academy of Dermatology.

A Role for Leukotriene Antagonists in Atopic Dermatitis?

J. Shupack, K. Washenik, L. Clark-Loeser, 2001, American journal of clinical dermatology.

STATUS OF MEDICAL TREATMENT FOR ANDROGENETIC ALOPECIA

M. Stiller, J. Shupack, M. Sasson, 1993, International journal of dermatology.

Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.

J. Shupack, J. Kitchin, K. Washenik, 1997, Journal of the American Academy of Dermatology.

Cyclosporine consensus conference: with emphasis on the treatment of psoriasis.

A. Gottlieb, M. Lebwohl, J. Koo, 1998, Journal of the American Academy of Dermatology.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

B. Elewski, J. Leyden, Sewon Kang, 1998, Journal of the American Academy of Dermatology.

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.

N. Konnikov, A. Bucko, N. Levine, 1998, Journal of the American Academy of Dermatology.

The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.

J. Carucci, D. Cohen, J. Shupack, 1998, Archives of dermatology.

Azaribine, homocystinemia, and thrombosis.

J. Shupack, C. Sansaricq, S. Snyderman, 1977, Archives of dermatology.

Histologic demonstration of intradermal spirochetes in a patient with Lyme disease.

P. Kantoff, J. Shupack, J. B. Greene, 1984, The American journal of the medical sciences.

Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease.

M. Stiller, J. Shupack, C. Kenny, 1992, Journal of the American Academy of Dermatology.

Ocular Side Effects of the Retinoids

J. Shupack, J. Gold, M. Nemec, 1989, International journal of dermatology.

A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis.

D. Cohen, M. Stiller, J. Shupack, 1994, Journal of the American Academy of Dermatology.

A CONCISE GUIDE TO TOPICAL SUNSCREENS: STATE OF THE ART

M. Stiller, J. Shupack, I. Davis, 1992, International journal of dermatology.

Long-Term Effects of Etretinate on the Liver in Psoriasis

G. Sidhu, H. Feiner, J. Shupack, 1987, The American journal of surgical pathology.

SYSTEMIC DRUGS IN THE TREATMENT OF DERMATOPHYTOSES

M. Stiller, J. Shupack, O. Sangueza, 1993, International journal of dermatology.

TREATMENT OE DERMATOPHYTOSES II: NEWER TOPICAL ANTIEUNGAL DRUGS

M. Stiller, J. Shupack, S. Rosenthal, 1993 .

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.

J. Leyden, S. Kang, L. Drake, 1998, Journal of the American Academy of Dermatology.

Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trials.

B. Elewski, N. Levine, A. Pandya, 1994, Journal of the American Academy of Dermatology.

Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.

B. Elewski, J. Hanifin, J. Hanifin, 1993, Journal of the American Academy of Dermatology.

Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials.

B. Berman, J. Leyden, M. Stiller, 1992, Journal of the American Academy of Dermatology.

Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.

L. Drake, J. Jorizzo, C. Ellis, 1991, Cutis.

Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.

B. Elewski, J. Hanifin, M. Stiller, 1995, Journal of the American Academy of Dermatology.

Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis

B. Reyes, T. Rosen, K. Beutner, 1998, International journal of dermatology.

Inocoterone and acne. The effect of a topical antiandrogen: results of a multicenter clinical trial.

C. Ellis, A. Lucky, M. Stiller, 1992, Archives of dermatology.

Tretinoin emollient cream: a new therapy for photodamaged skin.

E. Olsen, L. Lufrano, E. Thorne, 1992, Journal of the American Academy of Dermatology.

Topical alpha-interferon ointment with dimethyl sulfoxide in the treatment of recurrent genital herpes simplex.

M. Stiller, J. Shupack, C. Kenny, 1992, Dermatology.

Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.

B. Strober, J. Shupack, A. Alexis, 2005, Journal of the American Academy of Dermatology.

Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin).

L. Goldsmith, J. Shupack, A. Weinrich, 1982, Journal of the American Academy of Dermatology.

Efficacy of topical sensitizers in the treatment of alopecia areata.

J. Shupack, K. Washenik, C. Rokhsar, 1998, Journal of the American Academy of Dermatology.

Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.

J. Imperato-McGinley, K. Kaufman, E. Olsen, 1999, Journal of the American Academy of Dermatology.

The treatment of keratosis palmaris et plantaris with isotretinoin. A multicenter study.

P. Elias, W. Bergfeld, J. Shupack, 1982, Journal of the American Academy of Dermatology.

Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.

M. Lebwohl, G. Krueger, G. Weinstein, 1996, Journal of the American Academy of Dermatology.

Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.

Z. Draelos, C. Paul, J. Shupack, 2005, Journal of the American Academy of Dermatology.

Response of psoriatic nails to the aromatic retinoid etretinate.

H. Rabinovitz, J. Shupack, R. Scher, 1983, Archives of dermatology.

Oral and topical corticosteroids in bullous pemphigoid.

J. Bystryn, J. Shupack, B. Wainwright, 2002, The New England journal of medicine.

Acanthosis nigricans-like hyperpigmentation secondary to triazinate therapy.

J. Shupack, A. Greenspan, S. H. Foo, 1985, Archives of dermatology.

A 63-Year-Old Man With Chronic Penile Ulcers—Quiz Case

H. Kamino, J. Shupack, A. Kimyai-Asadi, 2003 .

A 63-year-old man with chronic penile ulcers.

H. Kamino, J. Shupack, A. Kimyai-Asadi, 2003, Archives of dermatology.

Ulcers of the leg in thalassemia.

D. M. Stevens, J. Shupack, R. Silber, 1977, Archives of dermatology.

Mal de Meleda treated with 13-cis retinoic acid.

F. Stengel, D. M. Benjamin, J. Shupack, 1979, Archives of dermatology.

Dose-response study of topical minoxidil in male pattern alopecia.

J. Shupack, T. Thirumoorthy, M. Reed, 1987, Journal of the American Academy of Dermatology.

Treatment of dermatophytoses II: Newer topical antifungal drugs.

M. Stiller, J. Shupack, S. Rosenthal, 1993, International Journal of Dermatology.

Treatment of keratoacanthomas with oral 13-cis-retinoic acid.

L. Dzubow, J. Shupack, M. Reed, 1980, The New England journal of medicine.

Necrobiosis lipoidica diabeticorum treated with chloroquine.

J. Shupack, K. Washenik, Khanh Nguyen, 2002, Journal of the American Academy of Dermatology.

A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.

R. Gilson, J. Weber, M. Conant, 1999, AIDS.

The future of topical therapy for cutaneous aging.

M. Stiller, J. Shupack, R. Haber, 1990, The Journal of dermatologic surgery and oncology.

Levodopa and melanoma

J. Shupack, A. Lieberman, 1974, Neurology.

Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies.

P. Pochi, G. Weinstein, E. Olsen, 1997, Journal of the American Academy of Dermatology.

A provocative case: phototesting does not reproduce the lesions of actinic granuloma

D. Cohen, J. Shupack, N. Soter, 2002, Photodermatology, photoimmunology & photomedicine.

Familial benign chronic pemphigus (Hailey-Hailey disease).

K. O'reilly, J. Shupack, R. Hunt, 2010, Dermatology Online Journal.

Psoriasis: To Cut or Not to Cut, What Say You?

J. Shupack, Ritu Saini, 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Histiocytosis X: treatment with topical nitrogen mustard.

B. Berman, J. Shupack, B. Berman, 1980, Journal of the American Academy of Dermatology.

Pharmacology of Therapeutic Agents in Photomedicine

M. Stiller, J. Shupack, I. Davis, 2018, Clinical Photomedicine.

Weekly low-dose methotrexate therapy for cutaneous sarcoidosis.

J. Shupack, G. Webster, M. Sanchez, 1991, Journal of the American Academy of Dermatology.

Resolving granuloma annulare with etanercept.

J. Shupack, K. Siu, 2006, Archives of dermatology.

Methotrexate with leucovorin rescue: A therapeutic alternative in severe psoriatics with a history of methotrexate-induced pancytopenia and diminished renal or hepatic function

M. Stiller, J. Shupack, M. Sasson, 1993 .

Pancytopenia following low-dose oral methotrexate therapy for psoriasis.

J. Shupack, G. Webster, 1988, JAMA.

Cutaneous pseudolymphoma resulting from antigen injections.

J. Shupack, H. Bernstein, B. Ackerman, 1974, Archives of dermatology.

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

James T. Elder, A. Gottlieb, M. Lebwohl, 2000, Journal of the American Academy of Dermatology.

Generalized essential telangiectasia.

J. Karen, H. Kamino, J. Shupack, 2008, Dermatology online journal.

Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.

B. Strober, J. Leyden, D. Thiboutot, 2006, Archives of dermatology.

Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab.

J. Mones, J. Shupack, J. G. Becker, 2012, Journal of the American Academy of Dermatology.

A comparison between Dactylaria gallopava and Scolecobasidium humicola: first report of an infection in a tortoise caused by S. humicola.

J. Shupack, S. Rosenthal, I. Weitzman, 1985, Sabouraudia.

Physician drug dispensing.

B. Thiers, J. Shupack, N. Penneys, 1988, Journal of the American Academy of Dermatology.

Antibody titers to an oxidized thymidine moiety are altered by systemic pharmacotherapy and by ultraviolet B phototherapy

M. Stiller, J. Shupack, K. Frenkel, 2004, Archives of Dermatological Research.

Syncope associated with liquid nitrogen therapy.

J. Shupack, A. Epstein, 1977, Archives of dermatology.

Human skin reaction to ethylene oxide.

S. R. Andersen, J. Shupack, S. J. Romano, 1981, The Journal of laboratory and clinical medicine.

Psoriasis and Reiter's syndrome.

M. Stiller, J. Shupack, R. Haber, 1991, Clinics in dermatology.

Adverse hepatic reactions associated with etretinate in patients with psoriasis--analysis of 22 cases.

J. Shupack, T. Thirumoorthy, 1988, Annals of the Academy of Medicine, Singapore.

Topical alpha-interferon in recurrent genital herpes simplex infection. A double-blind, placebo-controlled clinical trial.

M. Stiller, J. Shupack, E. Knobler, 1990, Dermatologica.

Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications.

P. Pochi, G. Weinstein, E. Olsen, 1997, Journal of the American Academy of Dermatology.